Sage Therapeutics, Inc.
SAGEDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597553
Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Sage Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +9 vs. Q4 2022
- Shares held
- 52.9M
- +1.24M (+2.4%) vs. Q4 2022
- Total value
- $2.22B
- +$252.9M (+12.8%) vs. Q4 2022
- New holders
- 33
- 76 more added
- Sold out
- 24
- 54 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $9 |
| Q1 2026 | 1 | $9 |
| Q4 2025 | 2 | $460.0K |
| Q3 2025 | 5 | $494.0K |
| Q2 2025 | 192 | $445.6M |
| Q1 2025 | 198 | $411.4M |
| Q4 2024 | 177 | $278.2M |
| Q3 2024 | 177 | $373.7M |
| Q2 2024 | 196 | $581.3M |
| Q1 2024 | 206 | $1.10B |
| Q4 2023 | 202 | $1.22B |
| Q3 2023 | 195 | $1.21B |
| Q2 2023 | 225 | $2.54B |
| Q1 2023 | 214 | $2.22B |
| Q4 2022 | 207 | $1.97B |
| Q3 2022 | 201 | $2.02B |
| Q2 2022 | 211 | $1.65B |
| Q1 2022 | 212 | $1.65B |
| Q4 2021 | 217 | $2.14B |
| Q3 2021 | 227 | $2.17B |
| Q2 2021 | 257 | $2.88B |
| Q1 2021 | 263 | $3.97B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Sage Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 946,138 | $39.7M | 0.01% | +220.0% | Added |
| Geode Capital Management, LLC | 1,040,245 | $43.6M | 0.01% | +32,815+3.3% | Added |
| Boxer Capital, LLC | 1,094,000 | $45.9M | 2.26% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 1,124,818 | $47.2M | 0.02% | +41,774+3.9% | Added |
| JPMorgan Chase & Co | 1,375,318 | $57.7M | 0.01% | −37,513−2.7% | Reduced |
| Marshall Wace, LLP | 1,411,929 | $59.2M | 0.15% | +479,006+51.3% | Added |
| Dimensional Fund Advisors LP | 1,654,700 | $69.4M | 0.02% | +335,966+25.5% | Added |
| Price T Rowe Associates Inc | 1,908,391 | $80.1M | 0.01% | +11,069+0.6% | Added |
| State Street Corp | 2,734,373 | $114.7M | 0.01% | +7,077+0.3% | Added |
| Bellevue Group AG | 3,090,000 | $129.7M | 1.88% | +120,722+4.1% | Added |
| BlackRock Inc. | 4,929,786 | $206.9M | 0.01% | +19,425+0.4% | Added |
| Vanguard Group Inc | 4,979,771 | $209.0M | 0.01% | +94,219+1.9% | Added |
| Wellington Management Group LLP | 5,714,423 | $239.8M | 0.05% | +198,287+3.6% | Added |
| FMR LLC | 7,083,533 | $297.2M | 0.03% | +532,042+8.1% | Added |
| Camber Capital Management LP | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −119,008−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Foundry Partners, LLC | 0 | $0 | 0.00% | −47,180−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −40,137−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −29,610−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −20,249−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −17,148−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,872−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,116−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −13,750−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −4,268−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,601−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −8,050−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −7,953−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −7,405−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −3,663−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −3,010−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Hall Laurie J Trustee | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| McElhenny Sheffield Capital Management, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Pendal Group Limited | – | – | – | – | Not filed |
| Neo Ivy Capital Management | – | – | – | – | Not filed |